Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when SYK files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsStryker reports 9.0% organic sales growth and 17.9% adjusted EPS growth in Q2 2026
Filed July 30, 2026 · Period ending July 30, 2026 · ~1 min read
Key Changes
-
high
Q2 2026 net sales reached $6.6 billion with 9.0% organic growth driven by volume gains across both MedSurg/Neurotechnology (9.2%) and Orthopaedics (8.6%) segments.
Exhibit 99.1 view on EDGAR → -
high
Adjusted EPS grew 17.9% to $3.69 as adjusted operating margin expanded 170 basis points to 27.4%, reflecting operational leverage and recovery from the cyber incident.
Exhibit 99.1 view on EDGAR → -
high
Management narrowed full-year 2026 guidance to 8.3%–9.3% organic sales growth and $14.95–$15.10 adjusted EPS, citing recovery momentum from the March 2026 cyber incident.
Exhibit 99.1 view on EDGAR → -
medium
Operating cash flow for the six months ended June 30, 2026 increased 35% to $1.842 billion from $1.361 billion in the prior-year period.
Exhibit 99.1 view on EDGAR →
Summary
Stryker reported strong second quarter 2026 results, with net sales of $6.6 billion representing 9.0% organic growth and adjusted earnings per share of $3.69, up 17.9% year-over-year. The performance marks a significant recovery from the cyber incident first disclosed in March 2026, with CEO Kevin Lobo noting the company has regained momentum across both major segments. Adjusted operating margin expanded 170 basis points to 27.4%, demonstrating operational leverage as the business normalized.
The company narrowed its full-year 2026 guidance, now expecting organic sales growth of 8.3% to 9.3% and adjusted EPS of $14.95 to $15.10. Operating cash flow for the first half of 2026 reached $1.842 billion, up 35% from the prior year, reflecting strong earnings growth and improved working capital management post-incident. The results suggest Stryker has successfully navigated the cyber disruption and returned to its position as a high-growth medical technology company.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Stryker announced Q2 2026 operating results via press release.
Added in current filing · verify on EDGAR →
Stryker Corporation issued a press release on July 30, 2026 announcing its second quarter 2026 operating results.
Stryker disclosed its second quarter 2026 operating results through a press release attached as Exhibit 99.1. The 8-K body does not contain specific financial figures; those would be in the exhibit.
Event · Exhibit 99.1
Added in current filing · view on EDGAR →
We made significant progress in our recovery from the cyber incident, delivering strong growth in sales, earnings per share and operating cash flow in the second quarter
CEO Kevin Lobo stated the company made significant progress recovering from a cyber incident (first reported March 11, 2026 per the forward-looking statements section), delivering strong Q2 results. The company has regained momentum and remains confident in its ability to grow at the high end of the medical technology sector.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jul 31, 2026 · How we verify